Tuesday, June 15News That Matters
Shadow

Pfizer-BioNTech start full U.S. approval application for COVID-19 vaccine – Reuters

Pfizer-BioNTech start full U.S. approval application for COVID-19 vaccine – Reuters

Pfizer Inc (PFE.N) and German partner BioNTech SA said on Friday they have started an application process with the U.S. Food and Drug Administration for full approval of their COVID-19 vaccine, currently only authorized for emergency use.

Read More…



Leave a Reply

Your email address will not be published. Required fields are marked *